Deciphex
4 FOLLOWERS
Deciphex, founded in 2019 by Richard Appleton, is a digital pathology company that uses artificial intelligence and machine learning to analyze histological images. Deciphex's flagship product, PATH, combines state-of-the-art image analysis algorithms with cloud-based data storage to provide pathologists with accurate and efficient diagnostic tools.
Deciphex
1y ago
To mark the recent launch of Patholytix AI 1.5, we describe how Patholyix AI fits in the technology landscape available to AI developers working on Pathology AI projects, and how the platform can benefit them in accelerating impactful data generation for their pathology stakeholders ..read more
Deciphex
1y ago
At Deciphex our mission is to enable our users to facilitate digital peer review of non-clinical pathology studies. We are delighted to announce the upcoming launch of Patholytix Preclinical 2.0 which provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners ..read more
Deciphex
1y ago
By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI ..read more
Deciphex
1y ago
To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data ..read more
Deciphex
1y ago
Deciphex and Charles River Laboratories International, Inc. (NYSE: CRL) have jointly announced today that they are the first in the industry to offer clients Good Laboratory Practice (GLP) validated digital peer review, using Deciphex Patholytix Preclinical for toxicologic pathology ..read more
Deciphex
1y ago
Deciphex is pleased to announce its success, in collaboration with partners Oncomark and UCD, in securing a €3m Government of Ireland, Disruptive Technologies Innovation Fund award to pursue its ongoing research program in cancer prognostics ..read more
Deciphex
1y ago
Deciphex, a leading provider of digital pathology and AI-powered services, announced that it has appointed Prof Runjan Chetty as Chief Medical Officer, Luke Benko as Vice President of Global Pathology Services and Chris Polley as Clinical Business Manager UK ..read more
Deciphex
1y ago
This latest release of our award winning digital pathology platform delivers significant workflow improvements for our users and provides even greater support for early stage research applications through the introduction of Quantitative Pathology ..read more
Deciphex
1y ago
Deciphex are pleased to announce our Gold Sponsorship of the 4th ESVP, ECVP and ESTP Cutting Edge Pathology Congress taking place on the 15th-17th of September ..read more
Deciphex
1y ago
Deciphex, a leading provider of digital pathology and AI-powered services for clinical and non-clinical pathology, today announced that it has launched it’s novel clinical diagnostics service Diagnexia ..read more